What is Affera?
Affera is a medical technology company dedicated to delivering innovative solutions to address the rapidly growing cardiac arrhythmia market. The company is developing a comprehensive integrated platform designed to efficiently deliver durable therapy for a broad spectrum of cardiac arrhythmia patients. This approach aims to streamline treatment pathways and improve patient outcomes in a field with substantial unmet needs.
How much funding has Affera raised?
Affera has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Affera
PPP
Public-Private Partnership
What's next for Affera?
With its large-scale, late-stage funding context, Affera is positioned for significant scaling and market penetration. The recent strategic investment suggests confidence from backers in the company's technology and its potential to capture a substantial share of the cardiac arrhythmia market. Future developments will likely focus on expanding clinical adoption, further refining its integrated platform, and potentially exploring new therapeutic applications or geographical markets. The company's trajectory indicates a move towards commercialization and solidifying its position as a key player in cardiovascular interventions.
See full Affera company page
